From April 1, 2023 to June 30, 2023, the company has repurchased 25,032 shares, representing 0.16% for $0.03 million. With this, the company has completed the repurchase of 517,399 shares, representing 3.5% for $0.63 million under the buyback announced on November 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1116 USD | +0.36% | +5.28% | -43.64% |
04-11 | Onconetix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
02-13 | Onconetix, Inc. Announces Appointment of Ajit Singh to its Board of Directors | CI |
1st Jan change | Capi. | |
---|---|---|
-43.64% | 3.48M | |
-2.32% | 90.45B | |
+3.68% | 41.45B | |
-10.90% | 33.57B | |
+58.05% | 25.73B | |
-19.56% | 14.73B | |
-9.06% | 12.82B | |
-11.34% | 11.7B | |
-43.53% | 11.44B | |
+3.75% | 8.79B |
- Stock Market
- Equities
- ONCO Stock
- News Onconetix, Inc.
- Tranche Update on Blue Water Biotech, Inc.'s Equity Buyback Plan announced on November 10, 2022.